Three-dimensional quantitative imaging of telomeres in buccal cells identifies mild, moderate, and severe Alzheimer's disease patients

Journal of Alzheimer's Disease

Volumn 39, Issue 1, 2014, Pages 35-48

  Mathur, Shubha ^a   Glogowska, Aleksandra ^a   McAvoy, Elizabeth ^b   Righolt, Christiaan ^a,c   Rutherford, Jaclyn ^a   Willing, Cornelia ^a   Banik, Upama ^a   Ruthirakuhan, Myuri ^b   Mai, Sabine ^a   Garcia, Angeles ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Alzheimer's disease; buccal mucosa; fluorescent in situ hybridization; genomic instability; telomeres; three dimensional image

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL AGGREGATION; CHEEK; CHROMOSOME NUMBER; CONTROLLED STUDY; CYTOARCHITECTURE; DISEASE SEVERITY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMAGING SOFTWARE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MIDDLE AGED; MOLECULAR PROBE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TELOMERE; TELOMERE HOMEOSTASIS; THREE DIMENSIONAL IMAGING; THREE DIMENSIONAL TELOMERIC ANALYSIS;

ALZHEIMER'S DISEASE; BUCCAL MUCOSA; FLUORESCENT IN SITU HYBRIDIZATION; GENOMIC INSTABILITY; TELOMERES; THREE-DIMENSIONAL IMAGE;

AGED; ALZHEIMER DISEASE; FEMALE; GENOMIC INSTABILITY; HUMANS; IMAGING, THREE-DIMENSIONAL; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MALE; MOUTH MUCOSA; REFERENCE VALUES; TELOMERE;

EID: 84892724815     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130866     Document Type: Article

References (77)

1. Watson JD (1972) Origin of concatemic T7 DNA. Nat New Biol 239, 197-201.
2. Olovnikov AM (1972) The immune response and the process of marginotomy in lymphoid cells. Vestn Akad Nauk SSSR 27, 85-87.
3. de Lange T (2005) Shelterin: The protein complex that shapes and safeguards human telomeres. Genes Dev 19, 2100-2110. (Pubitemid 41330312)
4. Kruk PA, Rampino NJ, Bohr VA (1995) DNA damage and repair in telomeres: Relation to aging. Proc Natl Acad Sci USA 92, 258-262.
5. Wynford-Thomas D, Kipling D (1997) The end replication problem. Nature 389, 551.
6. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89, 10114-10118.
7. Kipling D,Wynford-Thomas D, Jones CJ, Akbar A, Aspinall R, Bacchetti S, Blasco MA, Broccoli D, DePinho RA, Edwards DR, Effros RB, Harley CB, Lansdorp PM, Linskens MH, Prowse KR, Newbold RF, Olovnikov AM, Parkinson EK, Pawelec G, Ponten J, Shall S, Zijlmans M, Faragher RG (1999) Telomere-dependant senescence. Nat Biotechnol 17, 313-314.
8. Greider CW, Blackburn EH (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413. (Pubitemid 16213265)
9. Wojtyla A, Gladych M, Rubis B (2011) Human telomerase activity regulation. Mol Biol Rep 38, 3339-3349.
10. Muntoni A, Rendel RR (2005) The first molecular details of ALT in human tumor cells. Hum Mol Genet 14, R191-R196. (Pubitemid 41631887)
11. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D, Harley CB (1993) Loss of telomeric DNA during aging or normal and trisomy 21 human lymphocytes. Am J Hum Genet 52, 661-667. (Pubitemid 23310132)
12. Mai S (2010) Initiation of telomere-mediated chromosomal rearrangement in cancer. J Cell Biochem 109, 1095-1102.
13. Charames GS, Bapat B (2003) Genomic instability and cancer. Curr Mol Med 3, 589-596. (Pubitemid 37236402)
14. Meeker AK, Hicks JL, Iacobuzio-Donahue CA, Montgomery EA, Westra WH, Chan TY, Ronnett BM, De Marzo AM (2004) Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 10, 3317-3326. (Pubitemid 38685436)
15. Rampazzo E, Bertorelle R, Serra L, Terrin L, Candiotto C, Pucciarelli S, Del Bianco P, Nitti D, De Rossi A (2010) Relationship between telomere shortening, genomic instability, and site of tumor origin in colorectal cancers. Br J Cancer 102, 1300-1305.
16. Epel ES, Merkin SS, Cawthon R, Blackburn EH, Adler NE, Pletcher MJ, Seeman TE (2008) The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging (Albany NY) 1, 81-88.
17. Balasubramanyam M, Adaikalakoteswari A, Monickaraj SF, MohanV(2007) Telomere shortening and metabolic/vascular diseases. Indian J Med Res 125, 441-450.
18. Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I (2004) Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenital due to mutations in TERC. Nat Genet 36, 447-449. (Pubitemid 38620026)
19. Bessler M, Du HY, Gu B, Mason PJ (2007) Dysfunctional telomeres and dyskeratosis congenita. Haematologica 92, 1009-1012. (Pubitemid 350144205)
20. Batista LF, Pech MF, Zhong FL, Nguyen HN, Xie KT, Zuag AJ, Crary SM, Choi J, SebastianoV, Cherry A, Giri N,Wernig M, Alter BP, Cech TR, Savage SA, Reijo Pera RA, Artandi SE (2011) Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 474, 399-402.
21. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH (2001) Telomere shortening in atherosclerosis. Lancet 11, 472-473. (Pubitemid 32769858)
22. Jenkins EC, Velinov MT, Ye L, Gu H, Li S, Jenkins EC, Jr, Brooks SS, Pang D, Devenny DA, Zigman WB, Schupf N, Silverman WP (2006) Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia. Neurobiol Aging 27, 941-945.
23. Kume K, Kikukawa M, Hanyu H, TakataY, Umahara T, Sakurai H, Kanetaka H, Ohyashiki K, Ohyashiki JH, Iwamoto T (2012) Telomere length shortening in patients with dementia with Lewy bodies. Eur J Neurol 19, 905-910.
24. Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, Masterman D, Cummings JL, Effros RB (2003) Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 24, 77-84. (Pubitemid 35454145)
25. Jenkins EC, Ye L, Gu H, Ni SA, Duncan CJ, VelinovM, Pang D, Krinsky-McHale SJ, Zigman WB, Schupf N, Silverman WP (2008) Increased "absence" of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome. Neurosci Lett 440, 340-343.
26. Maeda T, Guan JZ,Koyanagi M, HiguchiY, MakinoN(2012) Aging-associated alteration of telomere length and subtelomeric status in female patients with Parkinson's disease. J Neurogenet 26, 245-251.
27. Thomas P, O'Callaghan NJ, FenechM(2008)Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease. Mech Ageing Dev 129, 183-190.
28. Alzheimer's, Association (2012) 2012 Alzheimer's disease facts and figures. Alzheimers Dement 8, 131-168.
29. Alzheimer Society of Canada, http://www.alzheimer.ca/en/About-dementia/ Alzheimer-s-disease/What-is-Alzheimer-s-disease, Last updated March 1, 2013, Accessed on March 6, 2013.
30. Frank EM (1994) Effect of Alzheimer's disease on communication function. J S C Med Assoc 90, 417-423.
31. Forstl H, Kruz A (1999) Clinical features of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 249, 288-290. (Pubitemid 30011730)
32. Taler V, Phillips NA (2008) Language performance in Alzheimer's disease and mild cognitive impairment: A comparative review. J Clin Exp Neuropsychol 30, 501-556. (Pubitemid 351883303)
33. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3, 186-191. (Pubitemid 46825511)
34. United, Nations (2013)World population prospects: The 2012 revision highlights. http://esa.un.org/unpd/wpp/Document ation/pdf/WPP2012 HIGHLIGHTS.pdf, Accessed on Augus 16, 2013.
35. National Institute on Aging, http://www.nia.nih.gov/alzhe imers/topics/symptoms, Accessed on March 8, 2013.
36. M̈ols̈a PK, Marttila RJ, Rinne UK (1986) Survival and cause of death in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand 74, 103-107. (Pubitemid 16016605)
37. M̈ols̈a PK, Marttila RJ, Rinne UK (1995) Long-term survival and predictors of mortality in Alzheimer's disease and multiinfarct dementia. Acta Neurol Scand 91, 159-164.
38. Migliore L, Testa A, Scarpato R, Pavese N, Petrozzi L, Bonuccelli U (1997) Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease. Hum Genet 101, 299-305. (Pubitemid 28197524)
39. Migliore L, Botto N, Scarpato R, Petrozzi L, Cipriani G, Bonuccelli U (1999) Preferencial occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer's disease patients. Cytogenet Cell Genet 87, 41-46. (Pubitemid 30021031)
40. Geller LN, Potter H (1999) Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease. Neurobiol Dis 6, 167-179. (Pubitemid 29297818)
41. Thomas P, Fenech M (2008) Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease. Mutagenesis 23, 57-65. (Pubitemid 351161354)
42. Juan JZ, Guan WP, Maeda T, Makino N (2012) Effect of vitamin E administration on the elevated oxygen stress and the telomeric and subtelomeric status in Alzheimer's disease. Gerontology 58, 62-69.
43. Nazarenko SA,TimoshevskyVA, SukhanovaNN(1999) High frequency of tissue-specific mosaicism in Turner Syndrome patients. Clin Genet 56, 59-65. (Pubitemid 29354012)
44. McKhann G, Drachman D, Folstein M, Katzman R, Price D, StadlanEM(1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on alzheimer's disease. Neurology 34, 939-944. (Pubitemid 14076461)
45. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G,Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746. (Pubitemid 47058377)
46. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (1995) The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53, 695-699.
47. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
48. McDowell I, Kristjansson B, Hill GB, Hebert R (1997) Community screening for dementia: The Mini Mental State Exam (MMSE) and Modified Mini-Mental State Exam (3MS) compared. J Clin Epidemiol 50, 377-383. (Pubitemid 27223266)
49. Herrmann N, Gauthier S (2008) Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease.CMAJ 179, 1279-1287.
50. Gauthier S, Patterson C, Chertkow H, Gordon M, Herrmann N, Rockwood K, Rosa-Neto P, Soucy JP (2012) 4th Canadian consensus conference on the diagnosis and treatment of dementia. Can J Neurol Sci 39, S1-S8.
51. Vermolen BJ, Garini Y, Mai S, Mougey V, Fest T, Chuang TC, Chuang AY,Wark L, Young IT (2005) Characterizing the three-dimensional organization of telomeres. Cytometry A 67, 144-150. (Pubitemid 41437531)
52. Cremer M, Grasser F, Lanctot C, Muller S, Neusser M, Zinner R, Solovei I, Cremer T (2008) Multicolor 3D fluorescence in situ hybridization for imaging interphase chromosomes. Methods Mol Biol 463, 205-239.
53. Schaefer LH, Schuster D, Herz H (2001) Generalized approach for accelerated maximum likelihood based image restoration applied to three-dimensional fluorescence microscopy. J Microsc 204, 99-107. (Pubitemid 33064464)
54. Gustafsson MGL (2000) Surpassing the lateral resolution limit by a factor of two using structured illumination microscopy. J Microsc 198, 82-87. (Pubitemid 30316807)
55. Poon SS, Martens UM, Ward RK, Lansdorp PM (1999) Telomere length measurements using digital fluorescence microscopy. Cytometry A 36, 267-278. (Pubitemid 29344462)
56. Chuang TC, Moshir S, Garini Y, Chuang AY, Young IT, Vermolen B, van den Doel R, MougeyV, Perrin M, Braun M,Kerr PD, Fest T, Boukamp P, Mai S (2004) The three-dimensional organization of telomeres in the nucleus of mammalian cells. BMC Bio 2, 12.
57. Nagele RG, Velasco AQ, Anderson WJ, McMahon DJ, Thomson Z, Fazekas J,Wind K, Lee H (2001) Telomere associations in interphase nuclei: Possible role in maintenance of interphase chromosome topology. J Cell Sci 114, 377-388. (Pubitemid 32149579)
58. Weierich C, Brero A, Stein S, von Hasse J, Cremer C, Cremer T, Solovei I (2003) Three-dimensional arrangements of centromeres and telomeres in nuclei of human and murine lymphocytes. Chromosome Res 11, 485-502. (Pubitemid 37041208)
59. De Vos WH, Hoebe RA, Joss GH, Haffmans W, Baatout S, Van Oostveldt P, Manders EM (2009) Controlled light exposure microscopy reveals dynamic telomere microterritories throughout the cell cycle. Cytometry A 75, 428-439.
60. Knecht H, Righolt C, Mai S (2013) Genomic instability: The driving force behind refractory/relapsing Hodgkin's lymphoma. Cancer 5, 7140725.
61. Louis SF, Vermolen BJ, Garini Y, Young IT, Guffei A, Lichtensztein Z, Kuttler F, Chuang TC, Moshir S, Mougey V, Chuang AY, Kerr PD, Fest T, Boukamp P, Mai S (2005) c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci USA 102, 9613-9618. (Pubitemid 40981729)
62. Duda RO, Hart PE (1973) Pattern Classification and Scene Analysis, 1st edition. Wiley-Interscience, New York, NY, USA.
63. Guffei A, Sarkar R, Klewes L, Righolt C, Knecht H, Mai S (2010) Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles. Haematologica 95, 2038-2046.
64. Adebayo Awe J, Xu MC, Wechsler J, Benali-Furet N, Cayre YE, Saranchuk J, Drachenberg D, Mai S (2013) Threedimensional telomeric analysis of isolated circulating tumor cells (CTCs) defines CTC subpopulations. Transl Oncol 6, 51-65.
65. Gadji M, Adebayo Awe J, Rodrigues P, Kumar R, Houston DS, Klewes L, Dieye TN, Rego EM, Passetto RF, de Oliveira FM, Mai S (2012) Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups. Clin Cancer Res 18, 3293-3304.
66. Sukenik-Halevy R, Fejgin M, Kidron D, Goldberg-Bittman L, Sharony R, Biron-Shental T, Kitay-Cohen Y, Amiel A (2009) Telomere aggregate formation in placenta specimens of pregnancies complicated with pre-eclampsia. Cancer Genet Cytogenet 195, 27-30.
67. Biron-Shental T, Sukenik-Halevy R, Sharon Y, Goldberg-Bittman L, Kidron D, Fejgin MD, Amiel A (2010) Short telomeresmayplay a role in placental dysfunction in preeclapsia and intrauterine growth restriction. Am J Obstet Gyneco 202, 381.
68. Hadi E, Sharony R, Goldberg-Bittman L, Biron-Shental T, Fejgin M, Amiel A (2009) Telomere aggregates in trisomy 21 amniocytes. Cancer Genet Cytogenet 195, 23-26.
69. Mounkes LC, Stewart CL (2004) Aging and nuclear organization: Lamins and progeria. Curr Opin Cell Biol 16, 322-327. (Pubitemid 38610414)
70. Righolt CH, van't Hoff ML, Vermolen BJ, Young IT, Raz V (2011) Robust nuclear lamina-based cell classification of aging and senescent cells. Aging (Albany NY) 3, 1192-1201.
71. Raz V, Vermolen BJ, Garini Y, Onderwater JJ, Mommaas-Kienhuis MA, Koster AJ, Young IT, Tanke H, Dirks RW (2008) The nuclear lamina promotes telomere aggregation and centromere peripheral localization during senescence of human mesenchymal stem cells. J Cell Sci 121, 4018-4028.
72. Sfeir A, de Lange T (2012) Removal of shelterin reveals the telomere end-protection problem. Science 336, 593-597.
73. Jacobs EG, Kroenke C, Lin J, Epel ES, Kenna HA, Blackburn EH, Rasgon NL (2013) Accelerated cell aging in female APOE-4 carriers: implications for hormone therapy use. PLoS One 8, e54713.
74. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, MorrowJD, CawthonRM(2004) Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 101, 17312-17315. (Pubitemid 39627816)
75. Mai S, Garini Y (2006) The significance of telomeric aggregates in the interphase nuclei of tumor cells. J Cell Biochem 97, 904-915.
76. Echave P, Conlon IJ, Lloyd AC (2007) Cell size regulation in mammalian cells. Cell Cycle 6, 218-224. (Pubitemid 46232503)
77. Riudavets M, Iacono D, Resnick SM, O'Brien R, Zonderman AB, Martin LJ, Rudow G, Pletnikova O, Troncoso JC (2007) Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons. Neurobiol Aging 10, 1484-1492 (Pubitemid 47238539)